138 related articles for article (PubMed ID: 30696836)
1. Biochemical and Proteomic Characterization of Recombinant Human α/β Hydrolase Domain 6.
Shields CM; Zvonok N; Zvonok A; Makriyannis A
Sci Rep; 2019 Jan; 9(1):890. PubMed ID: 30696836
[TBL] [Abstract][Full Text] [Related]
2. Full mass spectrometric characterization of human monoacylglycerol lipase generated by large-scale expression and single-step purification.
Zvonok N; Williams J; Johnston M; Pandarinathan L; Janero DR; Li J; Krishnan SC; Makriyannis A
J Proteome Res; 2008 May; 7(5):2158-64. PubMed ID: 18452279
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12).
Navia-Paldanius D; Savinainen JR; Laitinen JT
J Lipid Res; 2012 Nov; 53(11):2413-24. PubMed ID: 22969151
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potential of targeting α/β-Hydrolase domain-containing 6 (ABHD6).
Deng H; Li W
Eur J Med Chem; 2020 Jul; 198():112353. PubMed ID: 32371333
[TBL] [Abstract][Full Text] [Related]
5. WWL70 attenuates PGE
Tanaka M; Moran S; Wen J; Affram K; Chen T; Symes AJ; Zhang Y
J Neuroinflammation; 2017 Jan; 14(1):7. PubMed ID: 28086912
[TBL] [Abstract][Full Text] [Related]
6. The α/β-hydrolase domain 6 inhibitor WWL70 decreases endotoxin-induced lung inflammation in mice, potential contribution of 2-arachidonoylglycerol, and lysoglycerophospholipids.
Bottemanne P; Paquot A; Ameraoui H; Alhouayek M; Muccioli GG
FASEB J; 2019 Jun; 33(6):7635-7646. PubMed ID: 30896979
[TBL] [Abstract][Full Text] [Related]
7. Revisiting 1,3,4-Oxadiazol-2-ones: Utilization in the Development of ABHD6 Inhibitors.
Patel JZ; van Bruchem J; Laitinen T; Kaczor AA; Navia-Paldanius D; Parkkari T; Savinainen JR; Laitinen JT; Nevalainen TJ
Bioorg Med Chem; 2015 Oct; 23(19):6335-45. PubMed ID: 26344596
[TBL] [Abstract][Full Text] [Related]
8. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
Wen J; Ribeiro R; Tanaka M; Zhang Y
Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
[TBL] [Abstract][Full Text] [Related]
9. Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors.
Patel JZ; Nevalainen TJ; Savinainen JR; Adams Y; Laitinen T; Runyon RS; Vaara M; Ahenkorah S; Kaczor AA; Navia-Paldanius D; Gynther M; Aaltonen N; Joharapurkar AA; Jain MR; Haka AS; Maxfield FR; Laitinen JT; Parkkari T
ChemMedChem; 2015 Feb; 10(2):253-65. PubMed ID: 25504894
[TBL] [Abstract][Full Text] [Related]
10. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
Wen J; Jones M; Tanaka M; Selvaraj P; Symes AJ; Cox B; Zhang Y
J Neuroinflammation; 2018 Jan; 15(1):9. PubMed ID: 29310667
[TBL] [Abstract][Full Text] [Related]
11. Covalent inhibitors of human monoacylglycerol lipase: ligand-assisted characterization of the catalytic site by mass spectrometry and mutational analysis.
Zvonok N; Pandarinathan L; Williams J; Johnston M; Karageorgos I; Janero DR; Krishnan SC; Makriyannis A
Chem Biol; 2008 Aug; 15(8):854-62. PubMed ID: 18721756
[TBL] [Abstract][Full Text] [Related]
12. A Sensitive and Versatile Fluorescent Activity Assay for ABHD6.
Savinainen JR; Navia-Paldanius D; Laitinen JT
Methods Mol Biol; 2016; 1412():169-78. PubMed ID: 27245903
[TBL] [Abstract][Full Text] [Related]
13. Monoacylglycerol signalling and ABHD6 in health and disease.
Poursharifi P; Madiraju SRM; Prentki M
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():76-89. PubMed ID: 28880480
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometric characterization of the human androgen receptor ligand-binding domain expressed in Escherichia coli.
Zhu Z; Becklin RR; Desiderio DM; Dalton JT
Biochemistry; 2001 Sep; 40(36):10756-63. PubMed ID: 11535050
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
[TBL] [Abstract][Full Text] [Related]
16. Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of α/β-hydrolase domain containing 6 (ABHD6).
Hsu KL; Tsuboi K; Chang JW; Whitby LR; Speers AE; Pugh H; Cravatt BF
J Med Chem; 2013 Nov; 56(21):8270-9. PubMed ID: 24152295
[TBL] [Abstract][Full Text] [Related]
17. A Sensitive and Versatile Fluorescent Activity Assay for ABHD12.
Savinainen JR; Navia-Paldanius D; Laitinen JT
Methods Mol Biol; 2016; 1412():179-89. PubMed ID: 27245904
[TBL] [Abstract][Full Text] [Related]
18. Efficient Mass Spectral Analysis of Active Transporters Overexpressed in Escherichia coli.
Kawakami M; Juge N; Kato Y; Omote H; Moriyama Y; Miyaji T
J Proteome Res; 2018 Mar; 17(3):1108-1119. PubMed ID: 29350038
[TBL] [Abstract][Full Text] [Related]
19. Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines.
Rosa M; Bech-Serra JJ; Canals F; Zajac JM; Talmont F; Arsequell G; Valencia G
J Proteome Res; 2015 Aug; 14(8):3162-73. PubMed ID: 26090583
[TBL] [Abstract][Full Text] [Related]
20. Identification by MALDI-TOF mass spectrometry of 17 alpha-bromoacetamidopropylestradiol covalent attachment sites on estrogen receptor alpha.
Mattras H; Aliau S; Richard E; Bonnafous JC; Jouin P; Borgna JL
Biochemistry; 2002 Dec; 41(52):15713-27. PubMed ID: 12501200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
